Clinical Trial Update: Bevicizumab (Avastin) Infusion for Choroidal Neovascularization (CNV) Not Associated With Age-Related Macular Degeneration (AMD) [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating bevacizumab (Avastin) infusion for choroidal neovascularization not associated with age-related macular degeneration has been completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Choroidal Neovascularization
• Degenerative Myopia
• Pathological Myopia

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: Johns Hopkins University | Conditions: Choroidal Neovascularization, Degenerative Myopia | Phase 1 | Status: COMPLETED